45 related articles for article (PubMed ID: 15715080)
1. Molecular genetic analysis of oligodendroglial tumors.
Hartmann C; Mueller W; Lass U; Kamel-Reid S; von Deimling A
J Neuropathol Exp Neurol; 2005 Jan; 64(1):10-4. PubMed ID: 15715080
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Spencer Leal E; Faulkner CL; Palmer A; Wragg C; Jefferies S; Brandner S; Vale L; Higgins JP; Kurian KM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013387. PubMed ID: 35233774
[TBL] [Abstract][Full Text] [Related]
3.
Suchorska B; Unterrainer M; Biczok A; Sosnova M; Forbrig R; Bartenstein P; Tonn JC; Albert NL; Kreth FW
J Neurooncol; 2018 Sep; 139(3):721-730. PubMed ID: 29948765
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Baumert BG; Hegi ME; van den Bent MJ; von Deimling A; Gorlia T; Hoang-Xuan K; Brandes AA; Kantor G; Taphoorn MJB; Hassel MB; Hartmann C; Ryan G; Capper D; Kros JM; Kurscheid S; Wick W; Enting R; Reni M; Thiessen B; Dhermain F; Bromberg JE; Feuvret L; Reijneveld JC; Chinot O; Gijtenbeek JMM; Rossiter JP; Dif N; Balana C; Bravo-Marques J; Clement PM; Marosi C; Tzuk-Shina T; Nordal RA; Rees J; Lacombe D; Mason WP; Stupp R
Lancet Oncol; 2016 Nov; 17(11):1521-1532. PubMed ID: 27686946
[TBL] [Abstract][Full Text] [Related]
5. Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
Kunz M; Nachbichler SB; Ertl L; Fesl G; Egensperger R; Niyazi M; Schmid I; Tonn JC; Peraud A; Kreth FW
Cancer Med; 2016 Mar; 5(3):442-53. PubMed ID: 26714663
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnostics: techniques and recommendations for 1p/19q assessment.
Woehrer A; Hainfellner JA
CNS Oncol; 2015; 4(5):295-306. PubMed ID: 26545171
[TBL] [Abstract][Full Text] [Related]
7. Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.
Duval C; de Tayrac M; Michaud K; Cabillic F; Paquet C; Gould PV; Saikali S
PLoS One; 2015; 10(7):e0132125. PubMed ID: 26135922
[TBL] [Abstract][Full Text] [Related]
8. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
[TBL] [Abstract][Full Text] [Related]
9. ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas.
Duval C; de Tayrac M; Sanschagrin F; Michaud K; Gould PV; Saikali S
PLoS One; 2014; 9(6):e100342. PubMed ID: 24949947
[TBL] [Abstract][Full Text] [Related]
10. Correlation of histomorphologic prognostic markers and proliferative index with loss of heterozygosity 1p/19q and MGMT status in diffusely infiltrating gliomas.
Deb P; Mani NS; Sudumbrekar SM; Taneja N; Patrikar S
Med J Armed Forces India; 2013 Jul; 69(3):228-36. PubMed ID: 24600115
[TBL] [Abstract][Full Text] [Related]
11. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.
Sabha N; Knobbe CB; Maganti M; Al Omar S; Bernstein M; Cairns R; Çako B; von Deimling A; Capper D; Mak TW; Kiehl TR; Carvalho P; Garrett E; Perry A; Zadeh G; Guha A; Sidney Croul
Neuro Oncol; 2014 Jul; 16(7):914-23. PubMed ID: 24470545
[TBL] [Abstract][Full Text] [Related]
12. Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas.
Lass U; Hartmann C; Capper D; Herold-Mende C; von Deimling A; Meiboom M; Mueller W
Brain Pathol; 2013 May; 23(3):311-8. PubMed ID: 23107103
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1- mutation as common tumor initiating event.
Lass U; Nümann A; von Eckardstein K; Kiwit J; Stockhammer F; Horaczek JA; Veelken J; Herold-Mende C; Jeuken J; von Deimling A; Mueller W
PLoS One; 2012; 7(7):e41298. PubMed ID: 22844452
[TBL] [Abstract][Full Text] [Related]
14. Biology, genetics and imaging of glial cell tumours.
Walker C; Baborie A; Crooks D; Wilkins S; Jenkinson MD
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S90-106. PubMed ID: 22433833
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).
Grauer O; Pascher C; Hartmann C; Zeman F; Weller M; Proescholdt M; Brawanski A; Pietsch T; Wick W; Bogdahn U; Hau P
J Neurooncol; 2011 Sep; 104(3):801-9. PubMed ID: 21373969
[TBL] [Abstract][Full Text] [Related]
16. Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.
Stockhammer F; von Deimling A; Synowitz M; Blechschmidt C; van Landeghem FK
J Mol Histol; 2008 Oct; 39(5):553-60. PubMed ID: 18726700
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status?
Campbell BA; Horsman DE; Maguire J; Young S; Curman D; Ma R; Thiessen B
J Neurooncol; 2008 Aug; 89(1):37-45. PubMed ID: 18458822
[TBL] [Abstract][Full Text] [Related]
18. DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.
Kunitz A; Wolter M; van den Boom J; Felsberg J; Tews B; Hahn M; Benner A; Sabel M; Lichter P; Reifenberger G; von Deimling A; Hartmann C
Brain Pathol; 2007 Oct; 17(4):363-70. PubMed ID: 17610521
[TBL] [Abstract][Full Text] [Related]
19. Malignant glioma: neuropathology and neurobiology.
Preusser M; Haberler C; Hainfellner JA
Wien Med Wochenschr; 2006 Jun; 156(11-12):332-7. PubMed ID: 16944363
[TBL] [Abstract][Full Text] [Related]
20. Age at diagnosis and loss of heterozygosity on chromosome 1p and 19q in oligodendroglial tumors.
Hergersberg M; Mariani L; Vassella E; Murtin C; Weis J; Moschopulos M; Laeng H; Landolt H; Huber A; Roelcke U
J Neurooncol; 2006 Nov; 80(2):215-7. PubMed ID: 16685464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
